Interpace Biosciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Interpace Biosciences regular Real Value cannot be determined due to lack of data. The prevalent price of Interpace Biosciences is $0.0. Our model calculates the value of Interpace Biosciences from evaluating the firm fundamentals such as Return On Asset of -0.26, current valuation of 11.72 M, and Return On Equity of -2.85 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage locking in undervalued assets and disposing overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Interpace Biosciences Total Value Analysis
Interpace Biosciences is currently anticipated to have valuation of 11.72 M with market capitalization of 5.16 M, debt of 9.44 M, and cash on hands of 1.86 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Interpace Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.72 M | 5.16 M | 9.44 M | 1.86 M |
Interpace Biosciences Investor Information
About 28.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.12. Interpace Biosciences last dividend was issued on the 15th of January 2020. The entity had 1:10 split on the 15th of January 2020. Based on the key indicators related to Interpace Biosciences' liquidity, profitability, solvency, and operating efficiency, Interpace Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Interpace Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Interpace Biosciences has an asset utilization ratio of 107.51 percent. This implies that the OTC Stock is making $1.08 for each dollar of assets. An increasing asset utilization means that Interpace Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Interpace Biosciences Ownership Allocation
Interpace Biosciences secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Interpace Biosciences Profitability Analysis
The company reported the previous year's revenue of 41.31 M. Net Loss for the year was (14.94 M) with profit before overhead, payroll, taxes, and interest of 17.95 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Interpace Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Interpace Biosciences and how it compares across the competition.
Interpace Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Interpace Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.2 M | |
| Retained Earnings | -227.1 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Interpace OTC Stock
If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |